Brazil has suspended the clinical studies of Bharat Biotech's COVID-19 vaccine, Covaxin following termination of the company's agreement with its partner there, the South American Country's......
Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......
The Brazilian government on Wednesday announced temporary suspension of its 20 million dose COVID-19 vaccine contract with Bharat Biotech following allegations of irregularities in the deal, with......
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller......
Efforts are being ramped up for massive production of vaccines and make them available in the shortest possible time, a top government official said on Wednesday, stressing that India currently has......
Stocks of Oxford COVID-19 vaccine, Covishield, are likely to start moving out of Serum Institute of India's facility here on early Tuesday morning, days ahead of the nationwide inoculation drive,......
Department of Biotechnology is considering 12 novel research projects, initiated by leading bitechnology companies, in the country under the second round of Small Business Innovation Research......
As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for......
This is the amazing story of Dr Krishna M Ella, a scientist who turned into a serial entrepreneur. Krishna Ella, chairman and managing director of Bharat Biotech International Ltd, is one of the......
When the Andhra Pradesh government identified biotechnology as one of the engines of economic growth for the state, it came as a surprise for many. After all, Shantha Biotech and Bharat Biotech......